This acknowledgement allows Blue Belt Technologies to market STRIDETM outside the United States. Blue Belt Technologies Presidnet & CEO Eric Timko noted “Receiving CE Mark for STRIDETM is an important milestone for Blue Belt as we continue to expand our commercial footprint outside the United States,” according to the press release.
STRIDETM received FDA clearance in June 2014.
To learn more about STRIDETM, click here.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
